Earnings call transcript: Edwards Lifesciences Q4 2024 beats estimates, stock surges
Edwards Lifesciences Corp (NYSE:EW) reported strong financial results for the fourth quarter of 2024, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $0.59 against a ...
Earnings call transcript: STAAR Surgical Q4 2024 earnings miss, stock plunges
STAAR Surgical (NASDAQ:STAA) reported its Q4 2024 earnings, revealing a significant miss on both earnings per share (EPS) and revenue compared to forecasts. The company posted an EPS of -$0.69, far ...